PharVision Advisers’s Interparfums IPAR Stock Holding History

PharVision Advisers’s Portfolio IPAR Stock Details IPAR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-3,174	Closed	-$312K	–	841
2025 Q3	$312K	Buy	+3,174	New	+$374K	0.18%	206

Other funds holding IPAR

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

WHG

Westwood Holdings Group Dallas, Texas $13.7B AUM 21.48% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

First Trust Advisors Wheaton, Illinois $140B AUM 27.84% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return

Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return

PharVision Advisers's IPAR Position: Q4 2025 in Review

PharVision Advisers sold out of Interparfums (IPAR) in Q4 2025, closing a stake of 3,174 shares — an estimated $312K sold.

PharVision Advisers first reported a position in IPAR in Q3 2025 and held it in 1 quarter. The position peaked at $312K in Q3 2025. 286 funds tracked by Wall St. Rank hold IPAR as of Q4 2025.

PharVision Advisers reported no remaining Interparfums position as of Q4 2025 after selling out during the quarter.
PharVision Advisers sold 3,174 Interparfums shares in Q4 2025, an estimated $312K.
PharVision Advisers first reported a position in Interparfums in Q3 2025 and held it in 1 quarter.
PharVision Advisers's Interparfums position peaked at $312K in Q3 2025.
286 funds tracked by Wall St. Rank held Interparfums as of Q4 2025.

Based on PharVision Advisers's 13F filing for Q4 2025, filed 17 Feb 2026.